Lamia Lamrani

475 total citations
9 papers, 231 citations indexed

About

Lamia Lamrani is a scholar working on Hematology, Genetics and Rheumatology. According to data from OpenAlex, Lamia Lamrani has authored 9 papers receiving a total of 231 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hematology, 4 papers in Genetics and 2 papers in Rheumatology. Recurrent topics in Lamia Lamrani's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers), Platelet Disorders and Treatments (3 papers) and Acute Myeloid Leukemia Research (2 papers). Lamia Lamrani is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers), Platelet Disorders and Treatments (3 papers) and Acute Myeloid Leukemia Research (2 papers). Lamia Lamrani collaborates with scholars based in France, Australia and Germany. Lamia Lamrani's co-authors include Martine Jandrot‐Perrus, Benoît Ho‐Tin‐Noé, Stéphane Loyau, Véronique Ollivier, Bernhard Nieswandt, Varouna Syvannarath, Tobias Goerge, Cécile V. Denis, Yacine Boulaftali and Elizabeth E. Gardiner and has published in prestigious journals such as Blood, Thrombosis and Haemostasis and Journal of Thrombosis and Haemostasis.

In The Last Decade

Lamia Lamrani

7 papers receiving 230 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lamia Lamrani France 5 128 58 51 48 32 9 231
Ashley Ringrose Canada 5 182 1.4× 82 1.4× 46 0.9× 90 1.9× 33 1.0× 6 326
Lois W. Brüggemann Netherlands 10 88 0.7× 41 0.7× 16 0.3× 62 1.3× 30 0.9× 14 292
Rudy Fuentes United States 8 270 2.1× 41 0.7× 72 1.4× 109 2.3× 56 1.8× 12 444
Melania Carlisi Italy 10 105 0.8× 94 1.6× 27 0.5× 74 1.5× 68 2.1× 38 268
Shiyuan Zhou China 9 40 0.3× 58 1.0× 37 0.7× 55 1.1× 51 1.6× 33 258
Alexandre Slater United Kingdom 13 215 1.7× 47 0.8× 45 0.9× 67 1.4× 21 0.7× 27 342
Padma Priya Togarrati United States 8 71 0.6× 41 0.7× 56 1.1× 299 6.2× 53 1.7× 12 438
Jackline de Paula Ayres-Silva Brazil 7 40 0.3× 145 2.5× 42 0.8× 48 1.0× 48 1.5× 13 291
Jürgen Pinnecker Germany 4 85 0.7× 20 0.3× 82 1.6× 81 1.7× 32 1.0× 6 261
Adeline Blandinières France 11 29 0.2× 45 0.8× 25 0.5× 113 2.4× 25 0.8× 20 261

Countries citing papers authored by Lamia Lamrani

Since Specialization
Citations

This map shows the geographic impact of Lamia Lamrani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lamia Lamrani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lamia Lamrani more than expected).

Fields of papers citing papers by Lamia Lamrani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lamia Lamrani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lamia Lamrani. The network helps show where Lamia Lamrani may publish in the future.

Co-authorship network of co-authors of Lamia Lamrani

This figure shows the co-authorship network connecting the top 25 collaborators of Lamia Lamrani. A scholar is included among the top collaborators of Lamia Lamrani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lamia Lamrani. Lamia Lamrani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Lamrani, Lamia, et al.. (2024). Optimisation de l’efficacité et de la sécurité d’utilisation des lymphocytes CAR-T. médecine/sciences. 40(5). 445–453.
2.
Adam, Frédéric, Alexandre Kauskot, Lamia Lamrani, et al.. (2022). A gain‐of‐function filamin A mutation in mouse platelets induces thrombus instability. Journal of Thrombosis and Haemostasis. 20(11). 2666–2678. 6 indexed citations
3.
Lamrani, Lamia, Frédéric Adam, Christelle Soukaseum, et al.. (2022). New insights into regulation of αIIbβ3 integrin signaling by filamin A. Research and Practice in Thrombosis and Haemostasis. 6(2). e12672–e12672. 3 indexed citations
4.
Faille, Dorothée, Lamia Lamrani, Stéphane Loyau, et al.. (2020). Interferon Alpha Therapy Increases Pro-Thrombotic Biomarkers in Patients with Myeloproliferative Neoplasms. Cancers. 12(4). 992–992. 11 indexed citations
5.
Lamrani, Lamia, Christophe Marzac, Valérie Edmond, et al.. (2018). Differential Impact of Interferon Alpha on JAK2V617F and Calr Mutated Hematopoietic Stem and Progenitor Cells in Classical MPN. Blood. 132(Supplement 1). 4333–4333. 3 indexed citations
6.
Syvannarath, Varouna, Lamia Lamrani, Véronique Ollivier, et al.. (2015). Single platelets seal neutrophil-induced vascular breaches via GPVI during immune-complex–mediated inflammation in mice. Blood. 126(8). 1017–1026. 137 indexed citations
7.
Ajzenberg, Nadine, Dorothée Faille, Marie‐Geneviève Huisse, et al.. (2014). Aspirin in Philadelphia-Negative Myeloproliferative Neoplasms: What Is the Optimal Dose ?. Blood. 124(21). 3200–3200.
8.
Lamrani, Lamia, Catherine Lacout, Véronique Ollivier, et al.. (2014). Hemostatic disorders in a JAK2V617F-driven mouse model of myeloproliferative neoplasm. Blood. 124(7). 1136–1145. 43 indexed citations
9.
Loyau, Stéphane, Martine Jandrot‐Perrus, Marie‐Christine Bouton, et al.. (2012). The mouse dorsal skinfold chamber as a model for the study of thrombolysis by intravital microscopy. Thrombosis and Haemostasis. 107(5). 962–971. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026